Rhabdomyosarcoma - 25 Studies Found Completed : Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma : Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma : 2010-10-15 : Biological: Bevacizumab Given Active, not recruiting : Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features : Carcinoid Neuroendocrine : 2006-04-13 : Drug: Seneca Valley Virus (biological agent) Dose escalation (starting at 1 × 10^7 vp/kg), IV (in t Recruiting : Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma : Sarcoma : 2005-10-25 : Biological: dactinomycin Drug: cyclophosph Recruiting : Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma : Sarcoma : 2005-10-25 : Biological: dactinomycin Drug: cyclophosph NOT_YET_RECRUITING : Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease : Rhabdomyosarcoma : 2024-11-21 : Low -risk Administer IV push over 1 minute (or infusion via minibag as per institutional standards) on Day 1 of Weeks 1,8, 15 (3) doses.The m <<< Previous
